Premium
Databases in the area of pharmacogenetics
Author(s) -
Sim Sarah C.,
Altman Russ B.,
IngelmanSundberg Magnus
Publication year - 2011
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.21454
Subject(s) - pharmacogenomics , pharmacogenetics , biology , drug , drug response , identification (biology) , pharmacology , personalized medicine , computational biology , drug toxicity , drug development , bioinformatics , gene , genetics , genotype , botany
In the area of pharmacogenetics and personalized health care it is obvious that databases, providing important information of the occurrence and consequences of variant genes encoding drug metabolizing enzymes, drug transporters, drug targets, and other proteins of importance for drug response or toxicity, are of critical value for scientists, physicians, and industry. The primary outcome of the pharmacogenomic field is the identification of biomarkers that can predict drug toxicity and drug response, thereby individualizing and improving drug treatment of patients. The drug in question and the polymorphic gene exerting the impact are the main issues to be searched for in the databases. Here, we review the databases that provide useful information in this respect, of benefit for the development of the pharmacogenomic field. Hum Mutat 32:1–6, 2011. © 2011 Wiley‐Liss, Inc.